APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants
暂无分享，去创建一个
J. Rieusset | P. Moulin | B. Cariou | A. Caillaud | F. Venet | A. Janin | M. Di Filippo | A. Rimbert | S. Nony | O. Marmontel | M. Gossez | X. Vanhoye | W. Dijk | Pija Lindenbaum | Christine Durand | C. Chatelain